Overview

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Status:
Terminated
Trial end date:
2018-05-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate (Abatacept) for treatment of lupus nephritis when used on a background of Cellcept (mycophenolate) and prednisone (corticosteroids)
Phase:
Phase 3
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Abatacept
Mycophenolate mofetil
Mycophenolic Acid
Prednisone